Fructus Ligustrum lucidi inhibits inflammatory mediator release through inhibition of nuclear factor-κB in mouse peritoneal macrophages

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 9, 2007, Pages 1279-1285

  An, Hyo Jin ^a,b   Jeong, Hyun Ja ^a   Um, Jae Young ^a   Park, Yun Jum ^b   Park, Rae Kil ^b   Kim, Eun Cheol ^b   Na, Ho Jeong ^c   Shin, Tae Yong ^c   Kim, Hyung Min ^a   Hong, Seung Heon ^b  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGUSTRUM LUCIDUM EXTRACT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRUIT; INFLAMMATION; MALE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; DINOPROSTONE; FRUIT; I-KAPPA B PROTEINS; INFLAMMATION; LIGUSTRUM; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548451695     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.9.0013     Document Type: Article

References (26)

1. Chung, H. S., An, H. J., Jeong, H. J., Won, J. H., Hong, S. H., Kim, H. M. (2004) Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. J. Pharm. Pharmacol. 56: 129-134
2. Dai, Y., Hang, B. Q., Mong, Q. Y., Li, P. Z. (1989) Anti-inflammatory effect of fructus Ligustri Lucidi. Zhongguo Zhong Yao Za Zhi 14: 431-433, 448
3. Dinarello, C. A. (2000) Proinflammatory cytokines. Chest 118: 503-508
4. Ghosh, S., May, M. J., Kopp, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260
5. Harbrecht, B. G., Billiar, T. R., Stadler, J., Demetris, A. J., Ochoa, J. B., Curran, R. D., Simmons, R. L. (1992) Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit. Care Med. 20: 1568-1574
6. Harris, G. K., Qian, Y., Leonard, S. S., Sbarra, D. C., Shi, X. (2006) Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J. Nutr. 136: 1517-1521
7. Lappas, M., Permezel, M., Georgiou, H. M., Rice, G. E. (2002) Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 67: 668-673
8. Leiro, J. M., Alvarez, E., Arranz, J. A., Cano, E., Orallo, F. (2004) Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages. Int. Immunopharmacol. 4: 163-177
9. Li, M. L. (1994) Progress in the study on fructus Ligustri lucidi. Zhongguo Zhong Yao Za Zhi. 19: 504-506
10. Liu, J. (1995) Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49: 57-68
11. Liu, H., Shi, Y., Wang, D., Yang, G., Yu, A., Zhang, H. (2003) MECC determination of oleanolic acid and ursolic acid isomers in Ligustram lucidum Ait. J. Pharm. Biomed. Anal. 32: 479-485
12. Medzhitov, R., Janeway, C. A., Jr. (1997) Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9: 4-9
13. Murakami, M., Kudo, I. (2004) Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog. Lipid Res. 43: 3-35
14. Parrillo, J. E. (1993) Pathogenetic mechanisms of septic shock. N Engl. J. Med. 328: 1471-1477
15. Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D., Vallance, P. (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28: 34-39
16. Pfeilschifter, J., Muhl, H. (1999) Immunopharmacology: anti-inflammatory therapy targeting transcription factors. Eur. J. Pharmacol. 375: 237-245
17. Punzon, C., Alcaide, A., Fresno, M. (2003) In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors. Int. Immunopharmacol. 3: 1293-1299
18. Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., Ballard, D. W. (1995) Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. U S A 92: 11259-11263
19. Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C., Benoit, N. E., Xie, Q. W., Nathan, C., Gribble, G. W., Sporn, M. B. (1998) Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58: 717-723
20. Tegeder, I., Pfeilschifter, J., Geisslinger, G. (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb. J. 15: 2057-2072
21. Thanos, D., Maniatis, T. (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100
22. Vallance, P., Moncada, S. (1993) Role of endogenous nitric oxide in septic shock. New Horiz. 1: 77-86
23. Weinberg, J. B., Misukonis, M. A., Shami, P. J., Mason, S. N., Sauls, D. L., Dittman, W. A., Wood, E. R., Smith, G. K., McDonald, B., Bachus, K. E. (1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184-1195
24. Yamamoto, Y., Yin, M. J., Lin, K. M., Gaynor, R. B. (1999) Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem. 274: 27307-27314
25. Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., Franzoso, G., Carbone, M. (2006) TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc. Natl. Acad. Sci. U S A 103: 10397-10402
26. Zhang, Y., Lai, W. P., Leung, P. C., Wu, C. F., Yao, X. S., Wong, M. S. (2006) Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariecromized rats. Biol. Pharm. Bull. 29: 291-296